Leaders from the Massachusetts Consortium on Pathogen Readiness (MassCPR) discuss evolving priorities, progress, and the influence of their collaborative work on public policy and re-opening strategies in the wake of COVID-19.
Jagpreet Chhatwal, PhD, an assistant professor at Harvard Medical School and decision scientist at MGH Institute for Technology Assessment, discusses the challenges of building an interactive COVID-19 modeling tool and its real-world impact.
Robert M. Plenge, MD, PhD, senior vice president of research and early development, and head of the immunology, cardiovascular, fibrosis and global health research team at Bristol Myers Squibb, discusses leveraging genetic insights in drug discovery.
Lauren Orefice, PhD, assistant professor in the Department of Genetics at the Blavatnik Institute at Harvard Medical School, discusses steps toward translating promising science into novel treatments for autism.
A conversation with Stanley Y. Shaw, associate dean for Executive Education, about trends impacting health care, the importance of understanding the inner workings of the industry and how business leaders can create new value.
J. Michael McWilliams, MD, PhD, the Warren Alpert Foundation Professor of Health Care Policy at the Blavatnik Institute at Harvard Medical School and an internist at Brigham and Women’s Hospital, discusses hospital readmissions and pay-for-performance measures.
David Y. Ting, chief medical information officer of the Massachusetts General Physicians Organization in Boston and co-director of the MGH Center for Innovation in Digital HealthCare, discusses technologies aimed at easing administrative burden and provider burnout.
Genomic scientist George Church, PhD, professor of Genetics at Harvard Medical School, discusses approaches to genome editing and applications for organoids in drug discovery and development.
Anna Greka, MD, PhD, associate professor at Harvard Medical School, founding director of Kidney NExT at Brigham and Women’s Hospital and director of the Broad Institute Kidney Disease Initiative, discusses groundbreaking work on a rare kidney disease, prospects for new therapeutics and collaborating on drug development.
Isaac S. Kohane, MD, PhD, chair of the Department of Biomedical Informatics at Harvard Medical School, discusses promising uses and the path forward for artificial intelligence (AI) in health care.
Leemore S. Dafny, PhD, the Bruce V. Rauner Professor of Business Administration at Harvard Business School, discusses provider consolidation, the CVS-Aetna merger and the potential impact of Big Tech on health care consolidation.
Margaret “Molly” Hayes, MD, associate director of the Internal Medicine Residency Training Program and assistant director of the medical intensive care unit at Beth Israel Deaconess Medical Center (BIDMC), discusses handling uncertainty in critical care decision-making.
